🔎 Trials Near Me

홈 › 암 (전체) › 노스캐롤라이나

노스캐롤라이나의 암 (전체) 임상 시험

암 (전체) 관련 연구 91개가 노스캐롤라이나 내 여러 지역에서 참여자를 모집하고 있습니다.

노스캐롤라이나의 도시

공식 연구 텍스트(영어)

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

  • Duke Cancer Center Cary, Cary
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill
  • Duke University Medical Center, Durham
  • 외 3개
피험자 모집 중3상
18세 이상 · 여성 · 2026. 9. 28. 업데이트됨 · NCT05256225

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

  • UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill
  • Levine Cancer Institute, Charlotte
  • University of North Carolina Hospitals at Hillsborough, Hillsborough
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06989437

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

  • Messino Cancer Centers Asheville, Asheville
  • Duke University Medical Center, Durham
  • FirstHealth Cancer Center, Pinehurst
피험자 모집 중3상
18세 ~ 100세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT05920356

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

  • Levine Cancer Institute, Charlotte
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06150157

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

  • East Carolina University, Greenville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07195591

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

  • University of North Carolina at Chapel Hill, Chapel Hill
  • Duke University Medical Center - Duke Cancer Centre, Durham
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06901531

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

  • FirstHealth of the Carolinas- Speciality Center /ID# 279857, Pinehurst
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07365241

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

  • Quetzal Site 27, Chapel Hill
피험자 모집 중3상
18세 ~ 71세 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07504458

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

  • Lineberger Comprehensive Cancer Center, Chapel Hill
  • Atrium Health's Levine Cancer Institute, Charlotte
피험자 모집 중2상
12세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT02693535

Study of the Effect of Innate on the Inflammatory Response to Endotoxin

  • NIEHS Clinical Research Unit (CRU), Research Triangle Park
피험자 모집 중관찰 연구건강한 지원자 환영
18세 ~ 100세 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT01143480

Prospective Study to Assess a Diagnostic Aid for Cancer

  • Wilmington Health, PLLC, Wilmington
피험자 모집 중관찰 연구
45세 이상 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT07046260

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

  • The University of North Carolina at Chapel Hill, Chapel Hill
  • Levine Cancer Institute, Charlotte
  • Duke University Medical Center, Durham
  • 외 1개
피험자 모집 중2/3상
전 연령 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT03435796

Digital Art Therapy for Young Cancer Survivors

  • Lineberger Comprehensive Cancer Center, Chapel Hill
피험자 모집 중
18세 ~ 25세 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT06789666

Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC

  • Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill, Chapel Hill
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT06096038

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • University of North Carolina at Chapel Hill, Chapel Hill
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT07002034

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

  • University of North Carolina at Chapel Hill /ID# 272454, Chapel Hill
  • Atrium Health Levine Cancer Institute /ID# 271510, Charlotte
  • Wake Forest Baptist Health /ID# 271294, Winston-Salem
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT06953960

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

  • Research Site, Charlotte
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT05123482

A Phase 1/1b Study of IAM1363 in HER2 Cancers

  • Duke Cancer Institute, Durham
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT06253871

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • University of North Carolina Medical Center, Chapel Hill
  • Duke Cancer Institute, Durham
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT06119581

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

  • Oncology Specialists of Charlotte, Charlotte
  • Southern Oncology Specialists, Huntersville
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT07169851

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

  • Duke Cancer Center, Durham
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06252649

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

  • Regional Medical Oncology Center_Wlson, Wilson
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT06072612

Comprehensive Care for AYA: Needs Assessment Survey

  • Atrium Health Levine Cancer, Charlotte
  • Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
피험자 모집 중관찰 연구
15세 이상 · 모든 성별 · 2026. 8. 27. 업데이트됨 · NCT07196241

A Study of ARC-02 in B-cell NHL

  • Levine Cancer Institute, Charlotte
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 26. 업데이트됨 · NCT07691606

Project: Every Child for Younger Patients With Cancer

  • Mission Hospital, Asheville
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill
  • Carolinas Medical Center/Levine Cancer Institute, Charlotte
  • 외 4개
피험자 모집 중관찰 연구
25세 이하 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT02402244

Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer Survivors

  • University of North Carolina at Chapel Hill, Chapel Hill
피험자 모집 중
18세 ~ 39세 · 모든 성별 · 2026. 8. 24. 업데이트됨 · NCT06848491

Abatacept in Immune Checkpoint Inhibitor Myocarditis

  • University of North Carolina Chapel Hill, Chapel Hill
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT05335928

Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

  • Lineberger Comprehensive Cancer Center, Chapel Hill
피험자 모집 중1상
18세 ~ 99세 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT03454035

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • Duke University, Durham
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT05919264

Behavioral Pain Intervention for Older Cancer Patients

  • Duke Cancer Network, Durham
피험자 모집 중
55세 이상 · 여성 · 2026. 8. 12. 업데이트됨 · NCT07300995

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

  • Duke Cancer Institute, Durham
피험자 모집 중1상
18세 이상 · 남성 · 2026. 8. 10. 업데이트됨 · NCT06067841

Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes

  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill
피험자 모집 중건강한 지원자 환영
18세 ~ 99세 · 모든 성별 · 2026. 8. 10. 업데이트됨 · NCT07061652

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill
  • Duke University Medical Center, Durham
  • Duke Women's Cancer Care Raleigh, Raleigh
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 7. 업데이트됨 · NCT06580314

A Study of PHN-012 in Patients With Advanced Solid Tumors

  • PHN-012-001 Site, Durham
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 6. 업데이트됨 · NCT07127874

Distance-Based Exercise to Preserve Function and Prevent Disability

  • Novant Health Cancer Institute - Kernersville, Kernersville
  • Novant Health Cancer Institute - Mount Airy, Mount Airy
  • Novant Health Forsyth Medical Center, Winston-Salem
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 8. 5. 업데이트됨 · NCT07059884

Role of Mitochondrial Bioenergetics in Resilience for Gynecologic Cancer

  • Atrium Health Levine Cancer, Charlotte
  • Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
피험자 모집 중관찰 연구
50세 이상 · 여성 · 2026. 7. 30. 업데이트됨 · NCT07046936

Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer

  • FirstHealth of the Carolinas, Inc., Pinehurst
피험자 모집 중3상
18세 이상 · 여성 · 2026. 7. 28. 업데이트됨 · NCT07022483

A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy

  • Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Charlotte
  • Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
피험자 모집 중2상
18세 ~ 70세 · 모든 성별 · 2026. 7. 24. 업데이트됨 · NCT06866964

Patient Descriptors Of Cancer-Related Fatigue: A Mixed Methods Pilot Study Of Cancer Survivors

  • Levine Childrens Hospital Pediatric Cancer and Blood Disorders, Charlotte
  • Levine Cancer Institute, Charlotte
  • Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 7. 24. 업데이트됨 · NCT06634381

Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients

  • Levine Cancer Institute, Charlotte
피험자 모집 중2상
2세 ~ 21세 · 모든 성별 · 2026. 7. 23. 업데이트됨 · NCT04948619

ClinicalTrials.gov 출처, 2026. 9. 29. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.